查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984049

抗病毒布料市场：2026-2032年全球市场预测（依产品类型、抗病毒技术、布料类型、加工方法、应用、终端用户产业及通路划分）

Anti-Viral Fabric Market by Product Type, Antiviral Technology, Fabric Type, Treatment Method, Application, End Use Industry, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，抗病毒织物市场价值将达到 42.2 亿美元，到 2026 年将成长至 45.8 亿美元，到 2032 年将达到 75.1 亿美元，复合年增长率为 8.55%。

主要市场统计数据
基准年 2025 42.2亿美元
预计年份：2026年 45.8亿美元
预测年份：2032年 75.1亿美元
复合年增长率 (%) 8.55%

本文全面概述了抗病毒织物技术，并结合公共卫生优先事项、材料科学进步和商业性应用驱动因素进行了阐述。

抗病毒布料正逐渐成为纺织科学、公共卫生需求和工业创新交织的关键领域。过去十年，对能够主动灭活病毒颗粒的材料的投资已从小众的医疗应用转向更广泛的商业和消费用途。涂层化学、嵌入式金属离子和最后加工技术的创新，拓宽了设计师和製造商可选择的功能范围。同时，终端用户除了关注舒适性和耐用性等传统纤维特性外，也越来越重视其卫生性能。

加工化学、认证要求和供应链整合的进步如何重塑抗病毒织物的普及和竞争优势？

受技术成熟、监管日益严格以及消费者行为转变的推动，抗病毒织物市场格局正在经历一场变革。抗病毒整合技术的进步，例如金属离子和缓释基质的引入，使得织物具备持久的抗病毒性能，即使经过重复使用和洗涤也能保持有效。同时，基于奈米技术的表面处理和聚合物涂层降低了製造商改造现有生产线的门槛。除了这些技术基础之外，机构对基于纺织品的感染控制也越来越感兴趣，尤其是在医疗机构和人员密集的公共场所。

对 2025 年美国关税变化将给抗病毒织物价值链带来的成本压力、本地生产奖励和战略供应链重组进行评估。

美国宣布2025年实施的关税措施将引入新的因素，增加生产、加工或进口抗病毒织物及相关原材料的企业的业务运作复杂性。对特种化学涂料、某些成品纺织品以及用于抗病毒加工的进口组件征收更高的关税，可能会推高整个价值链的原材料成本，从而挤压利润空间。对于从海外采购活性成分的垂直整合型製造商而言，这些关税将促使其将关键原料在地化或与供应商重新谈判奖励以减轻关税负担。因此，采购团队正在审查供应商矩阵和总到岸成本模型，以在维持产品品质达标的同时，维持价格竞争力。

对产品类型、抗病毒技术、织物成分、应用、行业买家、加工方法和分销管道进行详细的细分映射，以指导策略优先排序。

市场区隔揭示了抗病毒织物创新如何与特定应用性能要求和商业性管道交织在一起。按产品类型划分，市场包括服装、过滤材料、家居布置和医用纺织品。服装又细分为休閒服、防护衣和运动服；过滤材料分为空气过滤和水过滤；家居布置涵盖床上用品、窗帘和室内装潢；医用纺织品包括医院床单、手术罩衣和创伤护理产品。每种产品层在耐用性、舒适性和监管方面都存在固有的限制，这些限制会影响加工方法和商业化策略的选择。依抗病毒技术划分，市场可分为「涂层织物」、「嵌入式製剂」和「奈米加工」。涂层织物包括金属涂层和聚合物涂层；嵌入式製剂包括铜离子和银离子的应用；奈米加工的特点是采用奈米铜和奈米银技术。技术选择会影响性能可持续性、可製造性和环境影响。

美洲、欧洲、中东和非洲以及亚太地区等地的需求因素、监管复杂性和製造专业化程度正在影响抗病毒布料的策略。

区域趋势正在形成差异化的需求模式和政策环境，这将对抗菌布料的应用轨迹产生重大影响。在美洲，大规模机构买家和契约製造正在推动对医院级解决方案和个人防护设备（PPE）的需求，而注重健康的都市区消费者则促进了日常服装和家用纺织品领域的创新。该地区供应链韧性和近岸外包的趋势正在推动对国内后整理和检验能力的投资，而监管也日益关注性能声明和环境安全。

在成熟的性能、可靠的供应和永续性透明度的驱动下，竞争动态正在推动整合技术和製造伙伴关係关係的发展。

一群成熟新兴企业正透过差异化的技术组合、策略伙伴关係和精准的商业化策略，重塑抗病毒织物市场。领先的化学品供应商正投资研发可融入聚合物基质或透过高效涂层系统赋予抗病毒特性的持久性抗病毒药物，而纺织品製造商和整理商则在建造检验能力，以满足机构采购要求。专注于最后加工和金属离子嵌入技术的新兴参与企业正在推出可缩短加工时间并提高耐洗性的专用工艺，这迫使成熟企业加快创新和伙伴关係策略的步伐。

领导者可采取切实可行的策略行动，以确保抗病毒药物的持续有效性、强大的供应链、合规的产品标籤以及有针对性的市场进入。

产业领导者应推动一系列合作倡议，以保障利润率、加速产品普及并降低合规风险。首先，他们应优先投资于检验的抗病毒技术，这些技术需兼顾耐用性和环境安全性，并实施独立测试以增强对采购的信心。其次，他们应调整供应链策略，透过供应商多元化、考虑国内加工流程以及与关键材料供应商谈判长期合同，来降低关税和原材料价格波动风险。第三，他们应设计能反映各通路需求的市场对市场模式。对于企业级产品，他们应优先考虑经销伙伴和直接交易；而对于消费品，则应充分利用数位化管道和品牌故事。

结合专家访谈、专利和标准审查、技术成熟度评估和供应链映射，研究途径严谨的混合方法，可以获得可靠的见解。

本研究采用综合分析方法，旨在整合技术、监管和商业性讯号。主要资讯来源包括对材料科学家、表面处理专家、医疗和酒店行业的采购经理以及检验化学品安全要求的监管顾问的结构化访谈。二级资讯来源包括关于抗病毒机制的同行评审文献、展示技术进步的专利申请、已发布的标准和测试方法，以及记录实施案例的行业白皮书。透过整合这些多元化的讯息，我们识别出持续存在的绩效瓶颈、监管转折点以及买方决策标准。

整合策略挑战，展示检验的抗病毒能力、供应链韧性和永续性可靠性如何决定市场领导地位。

总之，抗病毒织物代表着材料科学进步与紧迫的公共卫生和商业性需求相结合的一个机会领域。持久性嵌入式抗菌剂、先进涂层和奈米技术驱动的整理工艺正在拓展其实际应用范围，使其超越传统的医疗领域，涵盖消费服装、家用纺织品、过滤材料和酒店布草等领域。然而，成功的商业化需要可靠的检验、供应链的适应性以及对环境影响的考量。监管监测、关税压力以及区域製造业发展趋势的相互作用预计将继续影响哪些技术和市场进入模式能够取得成功。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：抗病毒织物市场：依产品类型划分

  • 服饰
    • 休閒装
    • 防护衣
    • 运动服
  • 过滤介质
    • 空气过滤
    • 水过滤
  • 内部的
    • 寝具
    • 窗帘
    • 室内装潢
  • 医用纺织品
    • 医院床位
    • 手术罩衣
    • 创伤护理

第九章：抗病毒布料市场：以抗病毒技术划分

  • 涂层织物
    • 金属涂层
    • 聚合物涂层
  • 植入式药物
    • 铜离子
    • 银离子
  • 奈米加工
    • 奈米铜
    • 奈米银

第十章：抗病毒布料市场：依布料类型划分

  • 混纺布料
    • 聚酯棉
    • 波利乌尔
  • 天然纤维
    • 棉布
    • 羊毛
  • 合成纤维
    • 尼龙
    • 聚酯纤维

第十一章：抗病毒织品市场：依处理方法划分

  • 独特加工
  • 表面处理

第十二章：抗病毒织物市场：依应用划分

  • 卫生保健
    • 诊所使用
    • 居家医疗
    • 对于医院
  • 家用纺织品
    • 寝具
    • 窗帘
    • 家具布料
  • 饭店业
    • 寝具
    • 纺织品
    • 制服
  • 个人防护设备
    • 手套
    • 罩衣
    • 面具
  • 运动服
    • 健身
    • 户外装备
    • 跑步服

第十三章：抗病毒布料市场：依终端用户产业划分

  • 汽车产业
  • 消费品
  • 医疗领域
  • 饭店业

第十四章：抗病毒布料市场：依通路划分

  • 直销
  • 销售代理销售
  • 线上销售

第十五章：抗病毒织物市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：抗病毒布料市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章：抗病毒布料市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国抗病毒织物市场

第十九章：中国抗病毒布料市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acme Group
  • Aditya Birla Fashion and Retail Limited
  • Albini Group
  • Arvind Ltd.
  • Berger Paints
  • Boyteks
  • Carrington Textiles Ltd.
  • Diesel SpA
  • Donear Industries Ltd.
  • D'Decor Home Fabrics Pvt. Ltd.
  • Grado Lab
  • HealthGuard Corporation Pty. Ltd.
  • HeiQ Materials AG
  • iFabric Corp.
  • Inner Mettle Inc. Ltd.
  • Polygiene Group
  • Raymond Ltd.
  • Rudolf GmbH
  • Shiva Texyarn Limited by Vedanayagam Hospital Private Limited
  • Siyaram Silk Mills Ltd.
  • SQ Group
  • Takisada-Nagoya Co., Ltd.
  • Toray Industries, Inc.
  • Wearwell (UK) Limited
  • Welspun
Product Code: MRR-2E76C3E47F63

The Anti-Viral Fabric Market was valued at USD 4.22 billion in 2025 and is projected to grow to USD 4.58 billion in 2026, with a CAGR of 8.55%, reaching USD 7.51 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.22 billion
Estimated Year [2026] USD 4.58 billion
Forecast Year [2032] USD 7.51 billion
CAGR (%) 8.55%

Comprehensive orientation to antiviral textile technologies contextualized within public health priorities, material science advances, and commercial adoption drivers

Antiviral fabrics are emerging as a critical intersection between textile science, public health imperatives, and industrial innovation. Over the past decade, investment in materials that actively neutralize viral particles has shifted from niche healthcare applications to broader commercial and consumer uses. Innovations in coating chemistries, embedded metallic ions, and nanofinishing techniques have expanded the functional palette available to designers and manufacturers, while end users increasingly prioritize hygiene performance alongside traditional textile attributes such as comfort and durability.

This introduction frames antiviral textile technologies within the broader context of risk mitigation and product differentiation. It highlights the convergence of regulatory scrutiny, consumer expectations, and supply chain modernization that together shape adoption pathways. By examining the underlying material science, treatment methods, and application domains, decision-makers can better understand where antiviral fabrics provide unique value and where conventional solutions remain sufficient. The goal of this section is to orient executive readers toward the strategic levers that influence investment choices and to clarify the technical and commercial criteria that define success in product development and market entry.

How advancements in treatment chemistry, certification expectations, and supply chain integration are reshaping adoption and competitive advantage in antiviral textiles

The landscape for antiviral fabrics is experiencing transformative shifts driven by technological maturation, regulatory tightening, and evolving buyer behavior. Advances in embedded agent approaches, such as metal ion incorporation and controlled-release matrices, are enabling durable antiviral performance that survives repeated use and laundering. Concurrently, nano-enabled surface treatments and polymer coatings have reduced application barriers for manufacturers seeking to retrofit existing production lines. These technological enablers are complemented by growing institutional interest in textile-mediated infection control, particularly in healthcare and high-density public venues.

At the same time, procurement patterns are changing as buyers demand verifiable performance and lifecycle considerations. Certification frameworks and standardized test protocols are emerging to distinguish credible antiviral claims from marketing rhetoric, which in turn influences supplier selection and pricing structures. Supply chain dynamics are also shifting: strategic sourcing of active materials, geographic diversification of finishing capacity, and closer collaboration between chemical suppliers and textile mills have reduced time-to-market for new antiviral products. Together, these shifts are creating new competitive frontiers where speed of validation, durability of treatment, and integrated supply chain capabilities determine who captures long-term value.

Assessment of how the 2025 United States tariff changes create cost pressures, localization incentives, and strategic supply chain reconfiguration for antiviral textile value chains

United States tariff policy announced for 2025 introduces a new vector of operational complexity for companies that produce, finish, or import antiviral fabrics and related inputs. Increased tariffs on specialty chemical coatings, certain finished textile products, and import components used in antiviral finishing can raise input costs and compress margins across the value chain. For vertically integrated manufacturers that source active agents internationally, the tariffs amplify incentives to localize critical supply or to renegotiate supplier agreements to mitigate duty exposure. As a result, procurement teams are reevaluating supplier matrices and total landed cost models to preserve price competitiveness while maintaining product integrity.

Beyond cost impacts, tariffs influence strategic decisions around where to locate finishing capacity and how to structure commercial contracts. Some organizations may accelerate domestic finishing investments to avoid repeated tariff exposure on intermediate goods, while others may redesign products to use alternative antiviral treatment methods that rely on locally sourced materials. Furthermore, tariffs tend to incentivize strategic stockpiling and longer purchasing cycles, which can strain working capital and create planning uncertainty. In this environment, companies that proactively model tariff scenarios, diversify input sources, and engage in cross-border supply chain planning are better positioned to maintain continuity and protect margins.

Detailed segmentation mapping across product categories, antiviral technologies, fabric compositions, applications, industry buyers, treatment methods, and distribution pathways to guide strategic prioritization

Segmentation reveals where antiviral textile innovations intersect with application-specific performance requirements and commercial pathways. Based on Product Type, the market encompasses Apparel, Filtration Material, Home Furnishing, and Medical Textiles, with Apparel subdivided into Casual Wear, Protective Clothing, and Sportswear; Filtration Material differentiated into Air Filtration and Water Filtration; Home Furnishing covering Bedding Products, Curtains, and Upholstery; and Medical Textiles spanning Hospital Bedding, Surgical Gowns, and Wound Care. Each product tier imposes distinct durability, comfort, and regulatory constraints, informing treatment choices and commercialization strategies. Based on Antiviral Technology, the landscape splits among Coated Fabric, Embedded Agent, and Nano Finishing, with Coated Fabric including Metal Coating and Polymer Coating, Embedded Agent covering Copper Ion and Silver Ion implementations, and Nano Finishing featuring Nano Copper and Nano Silver approaches. Technology selection affects performance longevity, manufacturability, and environmental profiles.

Further granularity emerges when considering Fabric Type: Blended Fabric such as Poly Cotton and Poly Wool, Natural Fabric like Cotton and Wool, and Synthetic Fabric including Nylon and Polyester each interact differently with antiviral chemistries, influencing adhesion, hand feel, and wash durability. Based on Application, antiviral fabrics are used across Healthcare, Home Textile, Hospitality, Personal Protection, and Sportswear, with Healthcare differentiated into Clinic Use, Home Healthcare, and Hospital Use; Home Textile into Bedding, Curtains, and Upholstery; Hospitality into Bedding, Textiles, and Uniforms; Personal Protection into Gloves, Gowns, and Masks; and Sportswear into Fitness Wear, Outdoor Gear, and Running Apparel. End Use Industry segmentation highlights Automotive Industry, Consumer Goods, Healthcare Sector, and Hospitality Industry as distinct buyers with unique procurement cycles and performance expectations. Treatment Method segmentation distinguishes Inherent Treatment from Surface Treatment, each offering trade-offs between permanence and retrofit flexibility. Finally, Distribution Channel considerations differentiate Direct Sales, Distributor Sales, and Online Sales, which shape customer engagement, pricing strategy, and post-sale service models.

Taken together, these segmentation lenses provide a multidimensional map that clarifies where technical innovation delivers the greatest commercial leverage, which buyer groups demand the highest certainty of performance, and how product design and go-to-market models should be adapted for each segment. This integrated view helps firms prioritize R&D investment, channel development, and certification efforts to align with segment-specific value propositions.

Regional demand drivers, regulatory complexity, and manufacturing specialization across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping antiviral fabric strategies

Regional dynamics create differentiated demand patterns and policy environments that materially influence adoption trajectories for antiviral fabrics. In the Americas, large institutional buyers and contract manufacturers drive demand for hospital-grade solutions and personal protective equipment, while consumer adoption in high-awareness urban centers pushes innovation toward everyday apparel and home textiles. Supply chain resilience and nearshoring trends in this region encourage investment in domestic finishing and validation capacity, and regulatory scrutiny is increasingly focused on performance claims and environmental safety.

Europe, Middle East & Africa presents a mosaic of regulatory frameworks and procurement behaviors. Strong sustainability mandates and rigorous chemical safety standards in many European markets place a premium on treatments that balance antiviral efficacy with eco-toxicological credentials. In the Middle East and Africa, demand is often event-driven and tied to government procurement cycles, though rapid infrastructure projects and hospitality sector growth are creating localized opportunities. Across this combined region, companies must navigate a complex interplay of certification regimes, sustainability reporting expectations, and heterogeneous purchasing protocols.

Asia-Pacific remains a central hub for textile manufacturing and finishing innovation, with integrated supply chains and advanced chemical processing capabilities that support rapid iteration of antiviral treatments. High-volume production capabilities and close proximity to raw material suppliers make this region a focal point for both technology development and cost-competitive manufacturing. However, rising labor costs and stricter environmental enforcement in key manufacturing countries are prompting investment in cleaner chemistries and more efficient finishing processes. Understanding these regional nuances is essential for firms seeking to align production footprint, regulatory compliance, and go-to-market timing across global portfolios.

Competitive dynamics driven by validated performance, supply reliability, and sustainability transparency that favor integrated technology and manufacturing partnerships

A set of incumbent and emerging companies are shaping the antiviral fabric landscape through differentiated technology portfolios, strategic partnerships, and targeted commercialization approaches. Leading chemical suppliers are investing in durable antiviral agents that can be integrated into polymer matrices or delivered via robust coating systems, while textile mills and finishers are building validation capabilities to meet institutional procurement requirements. New entrants focused on nanofinishing and metallic ion embedding are introducing specialized processes that reduce processing time and improve wash durability, forcing legacy players to accelerate innovation and partnership strategies.

Competition increasingly centers on three axes: performance validation, supply chain reliability, and sustainability transparency. Firms that can demonstrate reproducible antiviral efficacy under standardized test conditions, sustain supply of active materials, and provide clear environmental and safety data gain preferential access to large institutional contracts. Collaboration between chemical innovators, fabric manufacturers, and independent testing bodies is becoming a differentiator, as integrated value chains reduce time to market and lower technical risk for buyers. For buyers looking to enter or scale in this market, the competitive landscape favors partners who offer both technical credibility and the logistical infrastructure to support certification, large-scale finishing, and after-sale documentation.

Practical strategic actions for leaders to secure durable antiviral performance, resilient supply chains, compliant product claims, and targeted go-to-market execution

Industry leaders should pursue a coordinated set of actions that protect margins, accelerate adoption, and reduce compliance risk. First, prioritize investments in validated antiviral technologies that balance durability with environmental safety, and pursue independent testing to support procurement confidence. Second, align supply chain strategies to mitigate tariff exposure and input volatility by diversifying suppliers, exploring domestic finishing options, and negotiating longer-term agreements with key material providers. Third, design go-to-market models that reflect channel-specific needs: prioritize distribution partnerships and direct engagement for institutional buyers, while leveraging digital channels and brand storytelling for consumer-facing products.

In addition, leaders should integrate sustainability metrics into product development and commercial narratives to address regulatory trends and buyer expectations. Investing in lifecycle assessments and transparent chemical disclosure reduces procurement friction and differentiates offerings in tender processes. Finally, build cross-functional teams that bring together R&D, regulatory affairs, procurement, and commercial strategy to ensure that product claims are defensible, manufacturable at scale, and aligned with customer purchasing behaviors. These coordinated actions will increase the likelihood of successful product launches and sustainable market presence.

Rigorous mixed-method research approach combining expert interviews, patent and standards review, technology readiness evaluation, and supply chain mapping for robust insights

This research synthesis draws on a multi-method approach designed to triangulate technological, regulatory, and commercial signals. Primary inputs include structured interviews with material scientists, finishing specialists, procurement leaders in healthcare and hospitality, and regulatory consultants who monitor chemical safety requirements. Secondary sources encompass peer-reviewed literature on antiviral mechanisms, patent filings that reveal technology trajectories, publicly available standards and test methods, and industry white papers that document implementation case studies. These diverse inputs are synthesized to identify persistent performance constraints, regulatory inflection points, and buyer decision criteria.

Analytical methods include technology readiness assessments to evaluate durability and manufacturability, supply chain mapping to understand sourcing risk and tariff exposure, and competitive benchmarking to identify differentiators in validation and sustainability. Where possible, findings are corroborated across multiple data streams to reduce single-source bias. Throughout the research process, attention is paid to verifiability of antiviral claims, environmental and safety considerations, and the operational implications of scaling treatments from pilot to high-volume production. This methodology ensures that recommendations are grounded in both technical realities and commercial practicability.

Synthesis of strategic imperatives showing how validated antiviral performance, supply chain resilience, and sustainability credentials determine market leadership

In conclusion, antiviral fabrics represent an opportunity space where material science advances intersect with pressing public health and commercial needs. Durable embedded agents, sophisticated coatings, and nano-enabled finishes have broadened the set of feasible applications beyond traditional healthcare use cases into consumer apparel, home textiles, filtration media, and hospitality linens. However, successful commercialization requires credible validation, supply chain adaptability, and attention to environmental profiles. The interplay of regulatory scrutiny, tariff pressures, and regional manufacturing dynamics will continue to shape which technologies and go-to-market models succeed.

Organizations that combine validated performance data with resilient sourcing strategies and transparent sustainability credentials will have a decisive advantage. As adoption accelerates in targeted segments, early movers who invest in certification, local finishing capacity where needed, and clear communication of trade-offs between durability and environmental impact will be best positioned to capture institutional and premium consumer demand. Ultimately, antiviral fabrics will become another vector through which textile manufacturers demonstrate value, but the winners will be those who can reliably deliver verified performance at scale while managing the commercial and regulatory complexities that define this evolving market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anti-Viral Fabric Market, by Product Type

  • 8.1. Apparel
    • 8.1.1. Casual Wear
    • 8.1.2. Protective Clothing
    • 8.1.3. Sportswear
  • 8.2. Filtration Material
    • 8.2.1. Air Filtration
    • 8.2.2. Water Filtration
  • 8.3. Home Furnishing
    • 8.3.1. Bedding Products
    • 8.3.2. Curtains
    • 8.3.3. Upholstery
  • 8.4. Medical Textiles
    • 8.4.1. Hospital Bedding
    • 8.4.2. Surgical Gowns
    • 8.4.3. Wound Care

9. Anti-Viral Fabric Market, by Antiviral Technology

  • 9.1. Coated Fabric
    • 9.1.1. Metal Coating
    • 9.1.2. Polymer Coating
  • 9.2. Embedded Agent
    • 9.2.1. Copper Ion
    • 9.2.2. Silver Ion
  • 9.3. Nano Finishing
    • 9.3.1. Nano Copper
    • 9.3.2. Nano Silver

10. Anti-Viral Fabric Market, by Fabric Type

  • 10.1. Blended Fabric
    • 10.1.1. Poly Cotton
    • 10.1.2. Poly Wool
  • 10.2. Natural Fabric
    • 10.2.1. Cotton
    • 10.2.2. Wool
  • 10.3. Synthetic Fabric
    • 10.3.1. Nylon
    • 10.3.2. Polyester

11. Anti-Viral Fabric Market, by Treatment Method

  • 11.1. Inherent Treatment
  • 11.2. Surface Treatment

12. Anti-Viral Fabric Market, by Application

  • 12.1. Healthcare
    • 12.1.1. Clinic Use
    • 12.1.2. Home Healthcare
    • 12.1.3. Hospital Use
  • 12.2. Home Textile
    • 12.2.1. Bedding
    • 12.2.2. Curtains
    • 12.2.3. Upholstery
  • 12.3. Hospitality
    • 12.3.1. Bedding
    • 12.3.2. Textiles
    • 12.3.3. Uniforms
  • 12.4. Personal Protection
    • 12.4.1. Gloves
    • 12.4.2. Gowns
    • 12.4.3. Masks
  • 12.5. Sportswear
    • 12.5.1. Fitness Wear
    • 12.5.2. Outdoor Gear
    • 12.5.3. Running Apparel

13. Anti-Viral Fabric Market, by End Use Industry

  • 13.1. Automotive Industry
  • 13.2. Consumer Goods
  • 13.3. Healthcare Sector
  • 13.4. Hospitality Industry

14. Anti-Viral Fabric Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Distributor Sales
  • 14.3. Online Sales

15. Anti-Viral Fabric Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Anti-Viral Fabric Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Anti-Viral Fabric Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Anti-Viral Fabric Market

19. China Anti-Viral Fabric Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acme Group
  • 20.6. Aditya Birla Fashion and Retail Limited
  • 20.7. Albini Group
  • 20.8. Arvind Ltd.
  • 20.9. Berger Paints
  • 20.10. Boyteks
  • 20.11. Carrington Textiles Ltd.
  • 20.12. Diesel S.p.A.
  • 20.13. Donear Industries Ltd.
  • 20.14. D'Decor Home Fabrics Pvt. Ltd.
  • 20.15. Grado Lab
  • 20.16. HealthGuard Corporation Pty. Ltd.
  • 20.17. HeiQ Materials AG
  • 20.18. iFabric Corp.
  • 20.19. Inner Mettle Inc. Ltd.
  • 20.20. Polygiene Group
  • 20.21. Raymond Ltd.
  • 20.22. Rudolf GmbH
  • 20.23. Shiva Texyarn Limited by Vedanayagam Hospital Private Limited
  • 20.24. Siyaram Silk Mills Ltd.
  • 20.25. SQ Group
  • 20.26. Takisada-Nagoya Co., Ltd.
  • 20.27. Toray Industries, Inc.
  • 20.28. Wearwell (UK) Limited
  • 20.29. Welspun

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTI-VIRAL FABRIC MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANTI-VIRAL FABRIC MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CASUAL WEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PROTECTIVE CLOTHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AIR FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WATER FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURGICAL GOWNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY METAL COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYMER COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COPPER ION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SILVER ION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO COPPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NANO SILVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLY WOOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY WOOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY INHERENT TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SURFACE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CLINIC USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CURTAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UPHOLSTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY BEDDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY TEXTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY UNIFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GLOVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY GOWNS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY MASKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY FITNESS WEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY OUTDOOR GEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY RUNNING APPAREL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY AUTOMOTIVE INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY CONSUMER GOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE SECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL ANTI-VIRAL FABRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY MEDICAL TEXTILES, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY ANTIVIRAL TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY COATED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY EMBEDDED AGENT, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY NANO FINISHING, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY FABRIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY BLENDED FABRIC, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY NATURAL FABRIC, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY SYNTHETIC FABRIC, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOME TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY HOSPITALITY, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY PERSONAL PROTECTION, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY SPORTSWEAR, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPE ANTI-VIRAL FABRIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY APPAREL, 2018-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY FILTRATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 330. MIDDLE EAST ANTI-VIRAL FABRIC MARKET SIZE, BY HOME FURNISHING, 2018-203